Objective: The objective of this study is to investigate prenatal and perinatal determinants of school age blood pressure (BP) in former preterm, low birth weight infants.
Introduction
Compared with infants born full term, former preterm infants have higher blood pressure (BP) in adolescence and adulthood, with studies reporting systolic BP 2.4 to 13 mm Hg higher in former preterm infants compared with term-born controls. [1] [2] [3] [4] [5] [6] [7] [8] [9] Identifying the determinants of higher BP in this population may allow clinicians to identify which former preterm children and adults are at highest risk for developing hypertension and its sequelae later in life, and would also help elucidate the underlying mechanisms of fetal BP programming.
In animal models of fetal growth restriction, growth-restricted offspring develop sustained BP elevation after birth, 10 consistent with the biological phenomenon of developmental programming. In human populations born at or near term, investigators have found associations of fetal growth restrictionFas represented by lower birth weightFwith later BP elevation, 11 and have identified other prenatal determinants of higher BP, including preeclampsia, [12] [13] [14] [15] [16] other hypertensive disorders of pregnancy 17 and maternal smoking. 18 Little information exists regarding the extent to which these and other prenatal and perinatal factors influence later BP in preterm populations.
The objective of our study was to examine associations of maternal and child prenatal and perinatal factors with systolic BP at school age in a large sample of preterm, low birth weight infants.
Methods

Study design and participants
We performed a secondary analysis of data from the Infant Health and Development Program (IHDP), an eight-center longitudinal study of 1080 infants born at p37 completed weeks gestation and p2500 g that began in 1984 as a randomized trial of a post-discharge early child development intervention. Participants were enrolled in IHDP at the time of their newborn hospitalization. The methods of IHDP have been described elsewhere in detail. 19 The trial's primary outcomes related to cognitive development, behavior and health status have been reported through 18 years of age. [20] [21] [22] Institutional review boards for all participating centers approved the study and caregivers provided written informed consent.
Participants were eligible for this analysis if they were from one of the seven IHDP study sites that conducted a clinical exam, including BP at age 6.5 years. Of the 931 eligible participants, 809 (87%) completed any part of the age 6.5-year exam and of these, 694 (86%) had any BP data recorded. The main reason for missing BP data was that the study visit was completed at a location other than the IHDP clinical site, such as by telephone or in the mother's home. All 694 participants had data for at least one predictor variable, so they were included in the final sample for analysis.
Measurements
At the time of enrollment, study staff collected data regarding maternal and child health from the medical record, including birth weight, gestational age, birth order, maternal age and pregnancy and neonatal complications. Pregnancy complications including preeclampsia and other hypertensive disorders were recorded if they were noted in the medical record. Bronchopulmonary dysplasia was defined as requiring supplemental oxygen for >30 consecutive days or requiring ventilator therapy with chest X-ray findings consistent with the diagnosis. Mothers were interviewed regarding their weight (pre-conception and at delivery), smoking and alcohol intake during pregnancy and socio-demographic factors.
When children were 6.5 years old, study staff followed a standardized protocol to measure resting BP three times in the right arm by auscultation (n ¼ 164) or Dinamap automated oscillometric device Critikon, Tampa, FL, USA (n ¼ 530). The correct cuff size was chosen based on the measured mid-arm circumference. Staff also recorded the participants' behavioral state at the time of BP measurement as 'fully cooperative' or 'somewhat cooperative and fussy', and did not attempt to measure BP if the participant or parent refused (n ¼ 2).
Analysis
Our primary outcome was the mean systolic BP at age 6.5 years. Although systolic BP predicts later outcomes better than diastolic BP, 23 we also examined mean diastolic BP as a secondary outcome. Continuous predictors were maternal age, pre-pregnancy weight and gestational weight gain, and child birth weight, gestational age, birth order and fetal growth as represented by birth weight for gestational age Z-score based on a national reference. 24 Categorical predictors were pregnancy and neonatal complications including preeclampsia and other hypertensive disorders, gestational diabetes and bronchopulmonary dysplasia, fetal growth status, with small for gestational age (SGA) defined as birth weight for gestational age <10th percentile, and smoking and alcohol intake in pregnancy. We considered confounding by socio-demographic variables including maternal race/ethnicity, attained education level and annual household income, all assessed at the time of study enrollment.
We used multivariable linear regression to examine associations of predictor variables with the mean systolic and diastolic BP in mm Hg at 6.5 years, adjusting all analyses for the exact age in days at the time of BP measurement, measurement method (auscultation versus automated) and the child's behavioral state at the time of measurement. In examining the effect of gestational weight gain on BP, we additionally adjusted for gestational age at birth. We also adjusted estimates for socio-demographic variables and for height Z-score at age 6.5 years, based on the Centers for Disease Control growth reference, 25 because height is an important determinant of BP and may be affected by prenatal and perinatal factors. As IHDP included children born at a wide range of gestational ages, and to facilitate comparison with other published studies, 3, 5, 26 which included only very preterm infants, we stratified our fetal growth analyses by gestational age category (<32 weeks versus X32 weeks). We used SAS version 9.2 (SAS Institute, Cary, NC, USA) for all analyses.
Results
Characteristics of the 694 children included in this analysis and their mothers are shown in Table 1 . Median (range) birth weight was 1.87 (0.54, 2.50) kg and median (range) gestational age was 34 (25, 37) weeks. The median birth weight for gestational age Z-score, which reflects fetal growth was À1.1, showing that on average, fetal growth for this cohort was approximately 1 s.d. below the median for a contemporary national reference population. 24 Using the same reference population, 39% of this cohort was SGA, defined as having a birth weight for gestational age percentile <10. These characteristics were similar for the original IHDP cohort of 1080 children (data not shown). In comparison to the original IHDP cohort, mothers of children included in this analysis were somewhat more likely to be black (59 versus 53%) and less likely to have a college degree (28 versus 33%). Table 2 shows associations of maternal and child variables with systolic BP at 6.5 years. In model 1, estimates were adjusted for child age, sex, BP measurement conditions and socio-demographic variables. For each Z-score increment in birth weight for gestational age, systolic BP at age 6.5 years was 1.0 mm Hg higher (95% confidence interval (CI) 0.2, 1.9). Additional adjustment for height Z-score at 7 years (model 2) attenuated this estimate (0.7 mm Hg, 95% CI À0.1, 0.2). Children born SGA had systolic BP 0.7 mm Hg lower (95% CI À2.0, 0.6) than children born appropriate for gestational age. The presence of maternal hypertensive disorder was associated with higher systolic BP in the child (3.5 mm Hg, 95% CI 0.0, 7.0), but additional adjustment for maternal hypertensive disorder in the fetal growth models did not change the effect estimates, nor did adjustment for body mass index at 6.5 years (data not shown). None of the other maternal or child predictor variables was substantially associated with child systolic BP (Table 2) , nor was any predictor variable associated with diastolic BP (data not shown). In analyses stratified by BP method (auscultation or automated device), no statistically significant association of birth weight for gestational age Z-score with child systolic BP was identified for either method (for auscultation, 0.4 mm Hg per Z-score (95% CI À1.2, 1.9) and for automated device, 0.1 mm Hg per Z-score (95% CI À0.9, 1.1)). Results were also similar between methods for other predictor variables.
Consistent with findings in the overall sample, in analyses stratified by gestational age category (<32 weeks versus X32 weeks), greater fetal growth was associated with somewhat higher systolic BP in both gestational age categories (Table 3) , though results were not statistically significant.
Discussion
In full-term populations, numerous authors have reported that lower birth weight is associated with higher BP later in life, 11 but the majority of those studies did not consider separate effects of gestational length and fetal growthFboth determinants of birth weightFon later BP. Studies in full-term children suggest that SGA status at birth is a risk factor for later hypertension. 27 In contrast, our study, which included only children born preterm and low birth weight, found that fetal growth restriction was not associated with higher BP. In fact, we found that poorer fetal growth was associated with slightly lower systolic BP at school age, although the result was not statistically significant after adjustment for attained height.
A large study 26 of Dutch infants born at <32 weeks gestation and/or <1500 g (very low birth weight) also examined the association of fetal growth with later BP. That population-based study found no association of birth weight s.d. score, a measure of fetal growth, with systolic BP at age 19 years; our point estimate of 1.0 mm Hg per Z-score falls within that study's 95% CI of À0.7 to 1.7. Studies led by Hack et al. 3 in the United States and Doyle et al. 5 in Australia also failed to find an association of poorer fetal growth with higher BP later in life. Our study extends the findings of those studies, demonstrating that in heavier and more mature preterm infants, as well as in VLBW infants, fetal growth restriction does not appear to be a risk factor for later hypertension.
Additionally, in contrast to studies in full-term children, [12] [13] [14] we did not find that maternal preeclampsia was associated with higher school age BP. We also did not find an association of maternal smoking with offspring BP, in contrast to one study in a full-term cohort, 18 but consistent with the results of another. 28 A possible explanation for the discrepant findings between full-term and preterm populations relates to the timing of prenatal exposures. The developmental origins of health and disease paradigm rests on the hypothesis that exposures during critical periods of development, particularly fetal life and early infancy, can program long-term health. 29 It is possible that fetal growth restriction, preeclampsia and/or maternal smoking late in the third trimester influence BP, whereas the same exposures earlier in gestation, as experienced by infants born preterm, do not.
Studies 11, 30 in children born full term have found that more rapid weight gain in infancy is associated with higher BP later in life. However, the extent to which more rapid early weight gain leads to higher BP in preterm populations is unclear. In this cohort, faster weight gain in the first year of life was associated with only slightly higher (1.1 mm Hg per Z-score weight gain) systolic BP at age 6.5 years, only for children born at X32 weeks gestation. 31 Weight gain later in childhood may also be an important determinant of later BP in children born preterm. 15 Our study is limited by the fact that children in IHDP were born in the 1980's when clinical care of preterm, low birth weight infants differed from current practices. Additionally, obesityFan important determinant of BPFhas become substantially more prevalent since that time. A majority of IHDP mothers were poor, black and had attained low levels of education, possibly limiting generalizability, although participants were enrolled at eight centers across the country. Additionally, when compared with a contemporary reference population, 24 39% of our cohort was considered SGA. Thus, despite overall poorer fetal growth in our study population compared with a contemporary cohort, we still did not find an association of fetal growth restriction with higher BP. BP was measured by auscultation in some centers and oscillometric device in others, but associations of fetal growth and other predictor variables with BP were similar regardless of BP measurement method.
In summary, we found that, in former preterm low birth weight infants, slower fetal growth was not associated with higher BP later in life. Fetal growth restriction does not appear to be a risk factor for later hypertension in this population.
